Bayer

Last updated January 31, 2026

432

Innovation Areas

13,147

Inventors

104

Collaborations

Heteroaryl cyclamine scaffold derivatives: BayerRecent Research Landscape

Phytopathogenic resistance to legacy fungicides increases crop loss risks. These innovations engineer specific heterocyclic thioether and oxadiazole molecular architectures to restore chemical efficacy against evolving fungal strains.

What technical problems is Bayer addressing in Heteroaryl cyclamine scaffold derivatives?

Pathogenic fungal crop destruction

(17)evidences

Uncontrolled proliferation of harmful microorganisms on agricultural crops. Preventing this degradation protects yield and prevents economic loss from plant diseases.

Insufficient pharmacological potency

(15)evidences

Existing antibacterial treatments face declining efficacy due to evolving microbial defense mechanisms. Developing novel scaffolds overcomes therapeutic failure in treating infectious diseases.

Crop fungal pathogen resistance

(14)evidences

Existing fungicidal treatments are becoming ineffective due to pathogen adaptation. Overcoming this resistance ensures continued crop protection and yield stability.